A PHASE 1/2, OPEN-LABEL SAFETY, PHARMACOKINETIC AND EFFICACY STUDY OF TAS4464 IN PATIENTS WITH MULTIPLE MYELOMA OR LYMPHOMA

Type of Cancer
Multiple Myeloma

Sponsor
Taiho

Protocol Number
TAS4464-101

To Learn More Call
(201)-510-0950